News

First Human Clinical Investigation of the Next Generation Self-Assembling Haemostat [in progress]

The clinical investigation ‘First-in-Human Trial of the Safety and Performance of NU-MAX® as a...

PuraStat Inhibitory Effect on Post-Operative Abdominal Adhesion Formation: A Promising New Preclinical Randomized Animal Study

New animal data with PuraStat, a haemostatic absorbable hydrogel, is now available in the...

Notice regarding the submission for new manufacturing process for haemostatic products in Europe

We are pleased to announce that on the 13th January 2022, our European subsidiary 3-D Matrix Europe...

Global news: Japan Published Their First PuraStat Case Report

Last month, the first PuraStat case report in Japan was published. Written by Dr Takuto Hikichi (...

Study on PuraStat Reduces Postoperative Abdominal Adhesion Formation in an in vivo Model

The paper recently published evaluates the effect of PuraStat (RADA16) self-assembling peptide on...

Prof Di Bartolomeo Chairs 3-D Matrix Cardiac Symposium

On Thursday 14th October 2021, 3-D Matrix hosted a hybrid symposium, ‘Haemostasis in Cardiac Surgery

Study on PuraStat's Efficacy in Liver Resection Bleeding Now Published

New clinical trial data with PuraStat is now available in the publication “A multi-centre...

RCT Study: Exploring Efficacy of PuraStat in EMR Surgeries Goes Live

The clinical trial ‘Colorectal EMR & Delayed Bleeding: Prospective multicentre randomised...

PuraStat: The Impact on Patient Care Now and the Future

On Wednesday 20th October 2021, 3-D Matrix (in partnership with FUJIFILM) hosted its biannual...

Global News: Approval of PuraStat for NHI Reimbursement

PuraStat, absorbable haemostatic material, has been approved for the listing on Japan’s National...